Anzeige
Mehr »
Montag, 09.03.2026 - Börsentäglich über 12.000 News
Verdoppelt - und noch nicht am Ziel? Dieser Rohstoff-Explorer profitiert vom Antimon-Boom
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
115 Leser
Artikel bewerten:
(0)

Beacon Oral Specialists Enters Jacksonville with North Florida Oral & Facial Surgery Partnership

Latest New Market Entry Caps Year of Strategic Expansion and Positions Company for Strong 2026

DALLAS, TEXAS / ACCESS Newswire / March 9, 2026 / Beacon Oral Specialists, a portfolio company of Blue Sea Capital, announced today the completion of a successful year of growth in 2025 with its expansion into the Jacksonville market through a partnership with North Florida Oral & Facial Surgery (NFOFS), the leading oral and facial surgery practice in the region.

NFOFS operates five locations and is supported by a team of five surgeons serving the greater Jacksonville area. The practice was the fifth to join the Beacon Oral Specialists platform in 2025, alongside new partnerships in the Bay Area, Virginia, and Washington, D.C. As a result of this growth, Beacon now partners with more than 130 oral surgeons practicing across 106 locations in 12 states and Washington, D.C.

In addition to practice partnerships, Beacon added 13 associate oral surgeons to its existing practices nationwide in 2025. Continued patient demand, driven by the clinical excellence and reputations of Beacon's surgeon partners, also supported further expansion through four new practice launches in Las Vegas, Oahu, South Florida, and Chicago.

"2025 was a defining year for Beacon," said Mike Friguletto, Chief Executive Officer of Beacon Oral Specialists. "Our partnership with North Florida Oral & Facial Surgery reflects our continued focus on aligning with premier oral & maxillofacial surgeons in strategically important markets while supporting sustainable, long-term growth for our practices."

Beacon also celebrated its fifth anniversary in late 2025. The platform was formed in 2020 by Blue Sea Capital through the combination of two of the nation's largest oral and maxillofacial surgery platforms. From an initial base of two practices and 37 surgeons, Beacon has grown into one of the industry's leading oral & maxillofacial surgery-focused management services organizations, delivering strong organic growth while expanding its national footprint.

Looking ahead, Beacon remains well positioned to continue its growth trajectory, having finalized a new Georgia partnership in the early days of 2026, planning several new partnerships, office openings, and preparing to welcome a newly signed class of oral surgeon residency graduates to the platform later this year.

"Demand for the care from our surgeons remains strong. We are excited for the opportunities ahead of us to continue to broaden our often life-changing impact on oral health in communities across the country," Friguletto added.

About Beacon Oral Specialists

Beacon Oral Specialists (www.beaconoralspecialists.com) is a leading management services organization (MSO) exclusively serving the oral surgery sector. Beacon delivers world-class practice management solutions to a network of nationally renowned oral & maxillofacial surgeons across the United States. Its comprehensive support services include practice development, billing and collections, financial and accounting services, benefits and payroll administration, information technology, data analytics, vendor management, and legal support.

About Blue Sea Capital

Blue Sea Capital (www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida, that partners with growth-oriented, lower middle market companies and their entrepreneurial leadership teams. The firm manages more than $1.4 billion in assets and invests across three industry verticals: aerospace and defense, healthcare, and industrial growth. Blue Sea Capital typically serves as a first or second institutional investor, working closely with management teams to drive strategic growth, operational improvement, and long-term value creation.

Contact Information

Cindy Chapman
Vice President - Practice Development
cchapman@beaconoralspecialists.com
678-858-1325

SOURCE: Beacon Oral Specialists



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/beacon-oral-specialists-enters-jacksonville-with-north-florida-oral-a-1145004

© 2026 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.